Zurueck zur Suche

Reporte zur Charge NK45F

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

5Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
CA 1 AR 1 OR 1 MO 1

VAERS 1894178

GLAXOSMITHKLINE BIOLOGICALS · INFLUENZA (SEASONAL) (FLULAVAL QUADRIVALENT) · Charge NK45F

mild
Staat
-
Alter
32,0
Geschlecht
M
Eingang
23.11.2021
Impfdatum
19.10.2021
Beginn
20.10.2021
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: unbekannt
Testicular pain

Symptomtext

got booster and next day my testicals felt like i got kicked in them. coincidently after initially receiving my 1st and 2nd dose i had a thrombus in my right spermatic cord which led to me having a denervation of the right groin in june. Initially, my doctors chalked up the first incident to coincidence. after talking with my urologist, he had me do 2 weeks of nsaids, with only an increase in pain. now currently on 600mg gabapentin 3x a day with moderate relief. currently continuing to follow with urologist.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Testicular pain
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1861834

GLAXOSMITHKLINE BIOLOGICALS · INFLUENZA (SEASONAL) (FLUARIX QUADRIVALENT) · Charge NK45F

mild
Staat
CA
Alter
60,0
Geschlecht
M
Eingang
11.11.2021
Impfdatum
02.11.2021
Beginn
03.11.2021
Tage bis Beginn
1,0
Dosis
1
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Chills Headache Hyperhidrosis Pain Pyrexia

Symptomtext

FEVER 100.1-101.9, CHILLS, SWEATING, BODY ACHES, SLIGHT HEADACHE, LASTING 12-15 HOURS, BED REST. I TAKE ADVIL AND TRAMODOL FOR OTHER MEDICAL ISSUES. I DID NOT TAKE ADDITIONAL MEDICATION. FULL RECOVERY.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Chills
Hospital-Tage
-
Labordaten
NONE
Aktuelle Erkrankungen
NONE
Vorgeschichte
HIGH BP, ENLARGED PROSTATE,, DEPRESSION/ANXIETY
Andere Medikamente
WELLBUTRIN,BUSPAR,BYSTOLIC,CRESTOR,LOTREL,VALTREX,TAMSULOSIN
Allergien
PENICILLIN
Vorherige Impfungen
-

VAERS 2249419

GLAXOSMITHKLINE BIOLOGICALS · INFLUENZA (SEASONAL) (FLUARIX) · Charge NK45F

gering
Staat
AR
Alter
32,0
Geschlecht
M
Eingang
23.04.2022
Impfdatum
07.01.2022
Beginn
23.03.2022
Tage bis Beginn
75,0
Dosis
1
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Deafness unilateral

Symptomtext

Unilateral hearing loss; This is a spontaneous report received from a contactable reporter(s) (Physician). A 32-year-old male patient received BNT162b2 (BNT162B2), on 07Jan2022 as dose 3 (booster), single (Lot number: FH8027) at the age of 32 years for covid-19 immunisation; influenza vaccine inact split 3v (FLUARIX), on 07Jan2022 as dose 1, single (Lot number: NK45F), in arm for immunisation. The patient's relevant medical history included: "HIV" (unspecified if ongoing); "HTN" (unspecified if ongoing). Concomitant medication(s) included: TRIUMEQ; BIKTARVY; HCTZ. Vaccination history included: BNT162b2 (Dose Number: 2, Batch/Lot No: EN6200), administration date: 09Apr2021, when the patient was 32-year-old, for COVID-19 immunization; BNT162b2 (Dose Number: 1, Batch/Lot No: EN6204), administration date: 19Mar2021, when the patient was 31-year-old, for COVID-19 immunization. The following information was reported: DEAFNESS UNILATERAL (medically significant) with onset 23Mar2022, outcome "not recovered", described as "Unilateral hearing loss". The event "unilateral hearing loss" required physician office visit. Therapeutic measures were taken as a result of deafness unilateral.The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine.What treatment received for the adverse event was Steroids, no improvementPrior to vaccination, was the patient not diagnosed with COVID-19.Since the vaccination, has the patient not had been tested for COVID-19. No follow-up attempts are possible. No further information is expected.; Sender's Comments: As there is limited information in the case provided, the causal association between the reported event: "Deafness unilateral" and the suspect drug BNT162B2 cannot be excluded. The case will be reassessed once new information is available. The impact of this report on the benefit/risk profile of the Pfizer drug is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Deafness unilateral
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Medical History/Concurrent Conditions: HIV disease; Hypertension
Andere Medikamente
TRIUMEQ; BIKTARVY; HCTZ
Allergien
-
Vorherige Impfungen
-

VAERS 2160614

GLAXOSMITHKLINE BIOLOGICALS · INFLUENZA (SEASONAL) (FLUARIX QUADRIVALENT) · Charge NK45F

gering
Staat
OR
Alter
10,0
Geschlecht
M
Eingang
05.03.2022
Impfdatum
23.02.2022
Beginn
23.02.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Incorrect dose administered Product complaint Syringe issue

Symptomtext

Product Complaint; did not receive full dose; liquid shot out of the side of the syringe; This case was reported by a other health professional via call center representative and described the occurrence of incomplete dose administered in a 10-year-old male patient who received Flu Seasonal QIV Dresden (Fluarix Quadrivalent 2021-2022 season) (batch number NK45F, expiry date 30th June 2022) for prophylaxis. This case was associated with a product complaint. Co-suspect products included flu seasonal qiv dresden pre-filled syringe device (Fluarix Tetra Pre-Filled Syringe Device) injection syringe for prophylaxis. On 23rd February 2022, the patient received Fluarix Quadrivalent 2021-2022 season and Fluarix Tetra Pre-Filled Syringe Device. On 23rd February 2022, unknown after receiving Fluarix Quadrivalent 2021-2022 season and Fluarix Tetra Pre-Filled Syringe Device, the patient experienced incomplete dose administered and syringe leak. On an unknown date, the patient experienced pharmaceutical product complaint. On an unknown date, the outcome of the incomplete dose administered, syringe leak and pharmaceutical product complaint were unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional details were provided as follows: The reporter stated that, they had 3 cracked prefilled syringes of the Fluarix. The crack or breakage observed on the barrel of the syringe. The reporter stated that, she was administering Fluarix to the patient and once she injected into the patient's arm, the liquid shot out of the side of the syringe, which was cracked. She stated that, the patient did not receive the full dose as it was wasted, which led to incomplete dose administered. She claimed none of the medication touched the patient as it shot out into the air. She was unsure how much was leftover as the syringe was discarded. They only had one of the syringes to return as the other was discarded. The defect was discovered on an unknown site. It was unknown if healthcare professional preparing or administering vaccine was a new or experienced use. It was unknown if the package or carton or blister tray damaged upon receipt. There was no any evidence of leakage or product in package or carton. The product was still present in the syringe at the time of reporting. Full demographics for patient was unavailable. The reporter did not consent to follow up.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Incorrect dose administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1772086

GLAXOSMITHKLINE BIOLOGICALS · INFLUENZA (SEASONAL) (FLUARIX QUADRIVALENT) · Charge NK45F

gering
Staat
MO
Alter
60,0
Geschlecht
M
Eingang
08.10.2021
Impfdatum
04.10.2021
Beginn
05.10.2021
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Immediate post-injection reaction Muscle spasms Tetany

Symptomtext

Severe cramping /tetany of the left hand that occurred approximately 24 hours after vaccination. Symptom onset was immediate and lasted for 45 minutes before resolution.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Immediate post-injection reaction
Hospital-Tage
-
Labordaten
No labs drawn related to the event. Was seen by primary care nurse practitioner the day after the event and advised of stretching exercises and electrolyte supplementation.
Aktuelle Erkrankungen
N/A
Vorgeschichte
hypertension
Andere Medikamente
Allopurinol, Lisinopril, Amlodipine
Allergien
N/A
Vorherige Impfungen
-